Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome

Research output: Contribution to journalLetterOtherpeer-review

Original languageEnglish
Pages (from-to)565-568
Number of pages4
JournalBritish Journal of Clinical Pharmacology
Volume75
Issue number2
DOIs
Publication statusPublished - Feb 2013

Cite this

@article{b81ceacccff4445e994c270dd0833854,
title = "Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome",
author = "John Coutsouvelis and Meredith Wiseman and Lisa Hui and Susan Poole and Michael Dooley and Sushrut Patil and Sharon Avery and Andrew Wei and Andrew Spencer",
year = "2013",
month = "2",
doi = "10.1111/j.1365-2125.2012.04355.x",
language = "English",
volume = "75",
pages = "565--568",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "2",

}

Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome. / Coutsouvelis, John; Wiseman, Meredith; Hui, Lisa; Poole, Susan; Dooley, Michael; Patil, Sushrut; Avery, Sharon; Wei, Andrew; Spencer, Andrew.

In: British Journal of Clinical Pharmacology, Vol. 75, No. 2, 02.2013, p. 565-568.

Research output: Contribution to journalLetterOtherpeer-review

TY - JOUR

T1 - Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome

AU - Coutsouvelis, John

AU - Wiseman, Meredith

AU - Hui, Lisa

AU - Poole, Susan

AU - Dooley, Michael

AU - Patil, Sushrut

AU - Avery, Sharon

AU - Wei, Andrew

AU - Spencer, Andrew

PY - 2013/2

Y1 - 2013/2

UR - http://www.scopus.com/inward/record.url?scp=84879470650&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2125.2012.04355.x

DO - 10.1111/j.1365-2125.2012.04355.x

M3 - Letter

VL - 75

SP - 565

EP - 568

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 2

ER -